dabigatran has been researched along with 25-hydroxycholesterol in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (25-hydroxycholesterol) | Trials (25-hydroxycholesterol) | Recent Studies (post-2010) (25-hydroxycholesterol) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 853 | 3 | 243 |
| Protein | Taxonomy | dabigatran (IC50) | 25-hydroxycholesterol (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.3 | |
| Sterol regulatory element-binding protein 2 | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broncel, M; Gorzelak-Pabiś, P; Pawlos, A; Wojdan, K; Woźniak, E | 1 |
1 other study(ies) available for dabigatran and 25-hydroxycholesterol
| Article | Year |
|---|---|
Expression of anti and pro-inflammatory genes in human endothelial cells activated by 25-hydroxycholesterol: A comparison of rivaroxaban and dabigatran.
Topics: Administration, Oral; Anticoagulants; Atherosclerosis; Atrial Fibrillation; Cytokines; Dabigatran; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydroxycholesterols; Interleukin-18; Interleukin-23; Oxysterols; Rivaroxaban; RNA, Messenger; Transforming Growth Factor beta | 2022 |